Tamoxifen and the uterus: An old drug tested by new modalities

Ultrasound in Obstetrics and Gynecology

Volumn 7, Issue 5, 1996, Pages 374-378

  Achiron, R ^a   Grisaru, D ^b   Golan Porat, N ^b   Lipitz, S ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Blood flow; Endometrium; Saline contrast hysterosonography; Tamoxifen; Transvaginal sonography

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

BLOOD FLOW VELOCITY; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DOPPLER FLOWMETRY; DRUG EFFECT; ECHOGRAPHY; ENDOMETRIUM; FEMALE; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; UTERUS DISEASE; VAGINA; VASCULARIZATION;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD FLOW VELOCITY; BREAST NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; TAMOXIFEN; ULTRASONOGRAPHY, DOPPLER; UTERINE DISEASES; VAGINA;

EID: 0030137742     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1996.07050374.x     Document Type: Article

References (35)

1. Ziegler, L. J. and Buzdar, A. U. (1991). Current status of adjuvant therapy of early breast cancer. Am. J. Clin. Oncol., 14, 101-10
2. Early Breast Cancer Trialists' Collaborative Group (1992). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet, 339, 1-15, 71-85
3. Katzenellenbogen, B. S. (1991). Antiestrogen resistance: mechanisms by which breast cancer cells undermine the effectiveness of endocrine therapy. J. Natl. Cancer Inst., 83, 1434-5
4. Jordan, V. C. (1990). Long term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res. Treat., 15, 125-36
5. Huynh, H. and Pollak, M. (1994). Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin growth factor binding protein 3 gene expression. Cancer Res., 54, 3115-19
6. Boccardo, F., Bruzzi, P., Rubacotti, A., Nicolo, G. and Rosso, R. (1981). Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology, 38, 281-5
7. Ismail, S. M. (1994). Pathology of the endometrium treated with tamoxifen. J. Clin. Pathol., 47, 827-33
8. Fornander, T., Rutqvist, L. E., Cedermark, B., Glass, V., Mattsson, A., Silfver, S., Ward, C., Skoog, L., Somell, A., Theve, T., Wilking, N., Askergen, J. and Hjalmar, M. (1989). Adjuvant tamoxifen in early breast cancers: occurrence of new primary cancers. Lancet, 1, 117-20
9. van Leeuwen, F. B., Benraadt, J., Coebergh, J. W. W., Kiemeney, L. A. L. M., Gimbrere, C. H. F., Otter, R., Schouten, L. J., Damhuis, R. A. M., Bontenbal, M., Diepenhorst, F. W., van den Belt-Dusebout, A. W. and van Tinten, H. (1994). Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet, 343, 448-52
10. Fisher, B., Costantino, J. P., Fisher, E. R., Wickerham, D. L. and Cronin, W. M. (1994). Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project. J. Natl. Cancer Inst., 86, 527-37
11. Granberg, S., Wikland, M., Karlsson, B., Norstrom, A. and Friberg, L. (1991). Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am. J. Obstet. Gynecol., 164, 47-52
12. Neven, P., De Muylder, X., Van Belle, Y., Campo, R. and Vanderick, G. (1994). Tamoxifen and the uterus. Br. Med. J., 309, 1313-14
13. Anteby, E., Yagel, S., Zacut, D., Paldi, Z. and Hochner-Celniker, D. (1992). False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. Lancet, 340, 433-4
14. Hulka, C. A. and Hall, D. A. (1993). Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. Am. J. Roentgenol., 160, 809-12
15. Goldstein, S. R. (1994). Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am. J. Obstet. Gynecol., 170, 447-51
16. Perrot, N., Guyot, B., Antoine, M. and Uzan, S. (1994). The effects of tamoxifen on the endometrium. Ultrasound Obstet. Gynecol., 4, 83-4
17. Kurjak, A., Shelan, H., Kupesic, S., Predanic, M., Zalud, I., Breyer, B. and Jukic, S. (1993). Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet. Gynecol., 3, 137-54
18. Bourne, T. H., Campbell, S., Whitehead, M. I., Royston, P., Steer, C. V. and Collins, W. P. (1990). Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and colour flow imaging. Br. Med. J., 299, 369-73
19. Kurjak, A., Shalan, H., Sosic, A., Benic, S., Zudenigo, D., Kupesic, S. and Predanic, M. (1993). Endometrial carcinoma in postmenopausal women: evaluation by transvaginal color Doppler ultrasonography. Am. J. Obstet. Gynecol., 169, 1597-603
20. Kedar, R. P., Bourne, T. H., Powles, T. J., Collins, W. P., Ashley, S. E., Cosgrove, D. O. and Campbell, S. (1994). Effects of tamoxifen on the uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 343, 1318-21
21. Uziely, B., Lewin, A., Brufman, G., Dorembus, D. and Mor-Yosef, S. (1993). The effect of tamoxifen on the endometrium. Breast Cancer Res. Treat., 26, 101-5
22. Cohen, I., Rosen, D., Trepper, R., Cordova, M., Shai, Y., Altaras, M. M., Yigal, D. and Beyth, Y. (1993). Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J. Ultrasound Med., 5, 275-80
23. Lahti, E., Blanco, G., Kaupilla, A., Apaja-Sarkkinen, M., Taskinen, P. J. and Laatikainen, T. (1993). Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet. Gynecol., 81, 660-4
24. Achiron, R., Lipitz, S., Sivan, E., Goldenberg, M., Horovitz, A., Frenkel, Y. and Mashiach, S. (1995). Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet. Gynecol., 6, 116-20
25. Exacoustos, E., Zupi, E., Cangi, B., Chiaretti, M., Arduimi, D. and Romaninis, C. (1995). Endometrial evaluation in post-menopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler hysteroscopic and histological study. Ultrasound Obstet. Gynecol., 6, 435-442
26. Achiron, R., Lipitz, S., Sivan, M., Goldenberg, M. and Mashiach, S. (1995). Transvaginal sonohysterography for ultrasound evaluation of tamoxifen associated cystic thickened endometrium. J. Ultrasound Med., 14, 685-8
27. Nasri, M. N., Shepherd, J. H., Setchell, M. E., Lowe, D. G. and Chard, T. (1990). Role of vaginal scan in measurements of endometrial thickness in postmenopausal women. Br. J. Obstet. Gynaecol., 98, 470-5
28. Corley, D., Rowe, J., Curtis, M. T., Hogon, W. N., Noumoff, J. S. and Livolsi, W. A. (1992). Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet. Gynecol., 79, 111-16
29. Tawik, O. W., Huet, Y. M., Malathy, P. V., Johnson, D. C. and Dey, S. K. (1987). Release of prostaglandins and leukotrienes from the rat uterus is an early estrogenic response. Prostaglandins, 34, 805-14
30. Tawik, O. W., Sagrillo, C., Johnson, D. C. and Dey, S. K. (1987). Dedicualization in the rat: role of leukotrienes and prostaglandins. Prostaglandins Leukot. Med., 29, 221-7
31. Cohen, J. R., Luxman, D., Sagi, J., Yovel, I., Wolman, I. and David, M. P. (1994). Sonohysterography for distinguishing endometrial thickening from endometrial polyps in post-menopausal bleeding. Ultrasound Obstet. Gynecol., 4, 227-30
32. Dubinbsky, T. J., Parvey, H. R. and Gormaz, G. (1995). Transvaginal hysterosonography in the evaluation of small endoluminal masses. J. Ultrasound Med., 14, 1-6
33. Bourne, T. H., Lawton, F., Leather, A., Granberg, S., Campbell, S. and Collins, W. P. (1994). Use of intracavitary saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet. Gynecol., 4, 73-5
34. Tepper, R., Cohen, I., Altaras, M., Shapira, J., Cordoba, M., Dror, Y. and Beyth, Y. (1994). Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. J. Ultrasound Med., 13, 635-40
35. Achiron, R., Lipitz, S., Frenkel, Y. and Mashiach, S. (1995). Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic postmenopausal women: a transvaginal Doppler study. Ultrasound Obstet. Gynecol., 5, 411-14